Journal of Clinical Endocrinology & Metabolism, Vol 65, 814-816, Copyright © 1987 by Endocrine Society

ARTICLES

Absence of the plasma growth hormone-binding protein in Laron-type dwarfism

G Baumann, MA Shaw and RJ Winter
Department of Medicine, Northwestern University Medical School, Chicago, Illinois 60611.

We recently described a specific, high affinity binding protein (BP) for growth hormone (GH) in normal human plasma. Little is known about the source, regulation and biological role of this BP. Because its specificity is similar to that of the GH receptor, we considered the possibility that it represented a circulating receptor subunit or fragment. Laron-type dwarfism is a rare disorder characterized by severe growth failure, resistance to GH, and GH receptor deficiency. To probe the relationship between the receptor and the circulating binding protein, we measured the binding of GH to plasma from a child with Laron-type dwarfism and compared it with that in plasma of normal children and adults. Normal plasma samples were supplemented with unlabeled GH to the endogenous GH level in the plasma of the Laron patient to yield comparable saturation of the BP. After incubation of plasma with radiolabeled GH, bound GH was separated from free GH by gel filtration on Sephadex G-100. There was no detectable binding (less than 1.5%) of GH in the plasma of the Laron-type dwarf, whereas in normal children the bound GH fraction averaged 24.0 +/- 6.1% (mean +/- SD). Thus, the GH-BP is either absent or functionally abnormal in Laron- type dwarfism. This finding suggests that the circulating GH-BP is related to and/or may be derived from the GH receptor. Alternatively, it is possible that the BP plays an as yet poorly understood pivotal role in the promotion of somatic growth.

This article has been cited by other articles:

				Z. Laron Laron Syndrome (Primary Growth Hormone Resistance or Insensitivity): The Personal Experience 1958-2003 J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1031 - 1044. [Abstract] [Full Text] [PDF]

				P. A. Gruppuso The Clinical Laboratory Evaluation of GH Responsiveness J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 466 - 468. [Full Text] [PDF]

				T. Amit, M. B. H. Youdim, and Z.'e. Hochberg Does Serum Growth Hormone (GH) Binding Protein Reflect Human GH Receptor Function? J. Clin. Endocrinol. Metab., March 1, 2000; 85(3): 927 - 932. [Abstract] [Full Text]

				L. L. Anderson, D. L. Hard, A. H. Trenkle, and S.-J. Cho Long-Term Growth after Hypophyseal Stalk Transection and Hypophysectomy of Beef Calves Endocrinology, May 1, 1999; 140(5): 2405 - 2414. [Abstract] [Full Text]

				Y. Zhou, B. C. Xu, H. G. Maheshwari, L. He, M. Reed, M. Lozykowski, S. Okada, L. Cataldo, K. Coschigamo, T. E. Wagner, et al. A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse) PNAS, November 25, 1997; 94(24): 13215 - 13220. [Abstract] [Full Text] [PDF]

				K. A. Woods, F. Dastot, M. A. Preece, A. J. L. Clark, M.-C. Postel-Vinay, P. G. Chatelain, M. B. Ranke, R. G. Rosenfeld, S. Amselem, and M. O. Savage Phenotype: Genotype Relationships in Growth Hormone Insensitivity Syndrome J. Clin. Endocrinol. Metab., November 1, 1997; 82(11): 3529 - 3535. [Abstract] [Full Text] [PDF]

				S. I. Ymer, J. L. Stevenson, and A. C. Herington Guinea Pig Serum Contains a Specific High Affinity Growth Hormone-Binding Protein with Novel Ligand Specificity Endocrinology, September 1, 1997; 138(9): 3577 - 3586. [Abstract] [Full Text] [PDF]

				L. Baumbach, A. Schiavi, R. Bartlett, E. Perera, J. Day, M. R. Brown, S. Stein, M. Eidson, J. S. Parks, and W. Cleveland Clinical, Biochemical, and Molecular Investigations of a Genetic Isolate of Growth Hormone Insensitivity (Laron's Syndrome) J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 444 - 451. [Abstract] [Full Text] [PDF]

				F. I. Sharara and L. C. Giudice Role of Gorwth Hormone in Ovarian Physiology and Onest of Puberty Reproductive Sciences, January 1, 1997; 4(1): 2 - 7. [Abstract] [PDF]

				A. D. D'Andrea Cytokine Receptors in Congenital Hematopoietic Disease N. Engl. J. Med., March 24, 1994; 330(12): 839 - 846. [Full Text]

				W R Baumbach, D L Horner, and J S Logan The growth hormone-binding protein in rat serum is an alternatively spliced form of the rat growth hormone receptor. Genes & Dev., August 1, 1989; 3(8): 1199 - 1205. [Abstract] [PDF]